Regulations.gov document
Reference 8 - NAT for HBV and anti-HBc testing increase blood safety re Use of Nucleic…
Supporting & Related Material · FDA-2015-D-5073 · posted Aug 17, 2016
Key facts
| Document ID | FDA-2015-D-5073-0034 |
|---|---|
| Title | Reference 8 - NAT for HBV and anti-HBc testing increase blood safety re Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatits B Virus from Donors of Human Cells, Tissues, and Cellular and Tissue-Based Product Guidance for Industry |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2015-D-5073 |
| Posted | Aug 17, 2016 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: